Process of care and outcomes in patients with peripheral arterial disease

Journal of General Internal Medicine

Volumn 22, Issue 7, 2007, Pages 942-948

  Collins, Tracie C ^a,b,c   Beyth, Rebecca J ^d   Nelson, David B ^e   Petersen, Nancy J ^b,c   Suarez Almazor, Maria E ^f   Bush, Ruth L ^g   Hirsch, Alan T ^h   Ashton, Carol M ⁱ  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis risk factors; Glucose control; Peripheral arterial disease; Process of care; Surgery

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; BYPASS SURGERY; CAUCASIAN; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HISPANIC; HUMAN; LEG AMPUTATION; LIMB; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

AFRICAN AMERICANS; AGED; AMPUTATION; BLOOD GLUCOSE; COHORT STUDIES; DIABETES COMPLICATIONS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HOSPITALS, VETERANS; HUMANS; LIMB SALVAGE; LOWER EXTREMITY; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; TEXAS;

EID: 34250026746     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0203-7     Document Type: Article

References (35)

1. Collins T, Petersen N, Suarez-Almazor M, Ashton C. The prevalence of peripheral arterial disease in a racially diverse population. Arch Intern Med. 2003;163:1469-74.
2. Hirsch A, Criqui M, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24.
3. Newman A, Sutton-Tyrrell K, Kuller L. Lower-extremity arterial disease in older hypertensive adults. Arterioscler Thromb. 1993;13(4):555-62.
4. Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44:166-206.
5. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463-654.
6. Morise AP, McDowell DE, Savrin RA, et al. The prediction of cardiac risk in patients undergoing vascular surgery. Am J Med Sci. 1987;293(3):150-8.
7. Cheng SW, Ting AC, Lau H, Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg. 2000;14(2):158-65.
8. Harness N, Pinzur MS. Health related quality of life in patients with dysvascular transtibial amputation. Clin Orthop Relat Res. 2001;(383):204-7.
9. Mackey WC, McCullough JL, Conlon TP, et al. The costs of surgery for limb-threatening ischemia. Surgery. 1986;99:26-35.
10. Raviola C, Nichter L, Baker J, Busuttil R, Machleder H, Moore W. Cost of treating advanced leg ischemia: bpass graft vs. primary amputation. Arch Surg. 1988;123:495-6.
11. Weiss GN, Gorton TA, Read RC, Neal LA. Outcomes of lower extremity amputations. J Am Geriatr Soc. 1990;38(8):877-83.
12. National Institutes of Health: National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157-46.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285(19):2486-97.
14. American Diabetes Association Consensus Statement: Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333-41.
15. McAlister AL, Rabius V, Geiger A, Glynn TJ, Huang P, Todd R. Telephone assistance for smoking cessation: one year cost effectiveness estimations. Tob Control. 2004;13(1):85-6.
16. Stevenson RB. American Cancer Society and smoking cessation. J Am Dent Assoc. 1989;118(3):274.
17. Collins T, Johnson M, Henderson W, Khuri S, Daley J. Lower extremity non-traumatic amputation among veterans with peripheral arterial disease: is race an independent factor. Med Care. 2002;40(Suppl):I-106-16.
18. Criqui M, Langer R, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
19. Leng G, Fowkes F, Lee A, Dunbar J, Housley E, Ruckley C. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. Br Med J. 1996;313:1440-4.
20. McDermott M, Criqui M, Liu K, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg. 2000;32:1164-71.
21. McDermott M, Greenland P, Liu K, et al. The ankle-brachial index is associated with leg function and physical activity: The Walking and Leg Circulation Study. Ann Intern Med. 2002;136:873-83.
22. Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006;114:1914-22.
23. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg. 2000;31(1 Pt 2):S1-296.
24. Dawson DL, Cutler BS, Meissner MH, Strandness DE, Jr. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation. 1998;98:678-86.
25. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg. 1998;27:267-74.
26. Ernst E. Pentoxifylline for intermittent claudication: a critical review. Angiology. 1994;45:339-45.
27. Girolami B, Bernardi E, Prins MH, et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med. 1999;159:337-45.
28. Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials. CMAJ. 1996;155:1053-59.
29. Lindgarde F, Jelnes R, Bjorkman H, et al. Conservative drug treatment in patients with moderately severe chronic occlusive peripheral arterial disease. Circulation. 1989;80:1549-56.
30. Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. 1982;104:66-72.
31. Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med. 1990;113(2):135-46.
32. McDermott M, Mehta S, Liu K, et al. Leg symptoms, the ankle-brachial index, and walking ability in patients with peripheral arterial disease. J Gen Intern Med. 1999;14(3):173-81.
33. McDermott M, Hahn E, Greenland P, et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med. 2002;17(895):904.
34. Banta MR, Ma F, Bravata DM, Kirsner RS, Federman DG. Incidence of and factors associated with achieving target lipid levels in patients with peripheral arterial disease. J Gen Intern Med. 2006;21(7):711-4.
35. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000;11(5):561-70.